52 related articles for article (PubMed ID: 34750958)
1. Reconsidering the Trade-offs of Prostate Cancer Screening.
Shoag JE; Nyame YA; Gulati R; Etzioni R; Hu JC
N Engl J Med; 2020 Jun; 382(25):2465-2468. PubMed ID: 32558473
[No Abstract] [Full Text] [Related]
2. Elevated prostate-specific antigen (PSA) levels from acute COVID-19 infection confounding cancer disease surveillance.
Tan YJ; Tan Y
QJM; 2024 Jun; 117(5):378-379. PubMed ID: 38229252
[No Abstract] [Full Text] [Related]
3. Prostate-specific antigen screening for prostate cancer in countries with publicly funded health insurance.
Takahashi T
Public Health; 2023 Nov; 224():e2-e3. PubMed ID: 37258313
[No Abstract] [Full Text] [Related]
4. TRENDS IN PROSTATE CANCER DIAGNOSIS DURING THE COVID-19 PANDEMIC: SINGLE-INSTITUTION EXPERIENCE.
Ćudina I; Glavčić M; Hrabač P; Bulimbašić S; Ćorić M
Acta Clin Croat; 2023 Jul; 62(Suppl2):28-32. PubMed ID: 38966019
[TBL] [Abstract][Full Text] [Related]
5. A cross-section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID-19) era - a shifting paradigm?
Stroman L; Cathcart P; Lamb A; Challacombe B; Popert R
BJU Int; 2021 Jan; 127(1):30-34. PubMed ID: 32981180
[No Abstract] [Full Text] [Related]
6. [Not Available].
Schmidt J
MMW Fortschr Med; 2023 Oct; 165(Suppl 3):16. PubMed ID: 37857951
[No Abstract] [Full Text] [Related]
7. Association of plant-based diet index with prostate cancer risk.
Loeb S; Fu BC; Bauer SR; Pernar CH; Chan JM; Van Blarigan EL; Giovannucci EL; Kenfield SA; Mucci LA
Am J Clin Nutr; 2022 Mar; 115(3):662-670. PubMed ID: 34791008
[TBL] [Abstract][Full Text] [Related]
8. ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement.
Green S; Tuck S; Long J; Green T; Green A; Ellis P; Haire A; Moss C; Cahill F; McCartan N; Brown L; Santaolalla A; Marsden T; Justo MR; Hadley J; Punwani S; Attard G; Ahmed H; Moore CM; Emberton M; Van Hemelrijck M
Res Involv Engagem; 2021 Nov; 7(1):81. PubMed ID: 34789334
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis.
Kannan A; Clouston D; Frydenberg M; Ilic D; Karim MN; Evans SM; Toivanen R; Risbridger GP; Taylor RA
BJU Int; 2022 Oct; 130(4):420-433. PubMed ID: 34784097
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 amongst cancer patients: An experience from Oman.
Al Bahrani BJ; Mehdi I; Khamis FA; Al Farsi AM; Fahdi FA; Al Lawati NA
J Pak Med Assoc; 2021 Nov; 71(11):2563-2570. PubMed ID: 34783738
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.
Rolfo C; Meshulami N; Russo A; Krammer F; García-Sastre A; Mack PC; Gomez JE; Bhardwaj N; Benyounes A; Sirera R; Moore A; Rohs N; Henschke CI; Yankelevitz D; King J; Shyr Y; Bunn PA; Minna JD; Hirsch FR
J Thorac Oncol; 2022 Feb; 17(2):214-227. PubMed ID: 34774792
[TBL] [Abstract][Full Text] [Related]
12. Cash incentives, ethics, and COVID-19 vaccination.
Jecker NS
Science; 2021 Nov; 374(6569):819-820. PubMed ID: 34762480
[TBL] [Abstract][Full Text] [Related]
13. Genetics in prostate cancer: implications for clinical practice.
Szymaniak B; Ross AE; Morgans AK
Curr Opin Support Palliat Care; 2021 Dec; 15(4):241-246. PubMed ID: 34762074
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.
Matovina Brko G; Popovic M; Jovic M; Radic J; Bodlovic Kladar M; Nikolic I; Vidovic V; Kolarov Bjelobrk I; Kukic B; Salma S; Litavski J; Petrovic N; Vranjkovic B; Roganovic T; Ruzic M; Dugandzija T; Popovic L
J BUON; 2021; 26(5):2183-2190. PubMed ID: 34761633
[TBL] [Abstract][Full Text] [Related]
15. An Italian Model for the Management of Cancer Patients during COVID-19 Pandemic: The Regional Center for Oncological Orientation (COrO) of Taranto (ROP).
Pisconti S; Modoni G; Cafiero C; Simeone G; Surico G; Gorgoni G
Med Princ Pract; 2022; 31(1):54-58. PubMed ID: 34753134
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of apolipoproteins in COVID-19 patients: A systematic review and meta-analysis.
Ulloque-Badaracco JR; Hernandez-Bustamante EA; Herrera-Añazco P; Benites-Zapata VA
Travel Med Infect Dis; 2021; 44():102200. PubMed ID: 34752921
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
Naranbhai V; Pernat CA; Gavralidis A; St Denis KJ; Lam EC; Spring LM; Isakoff SJ; Farmer JR; Zubiri L; Hobbs GS; How J; Brunner AM; Fathi AT; Peterson JL; Sakhi M; Hambelton G; Denault EN; Mortensen LJ; Perriello LA; Bruno MN; Bertaux BY; Lawless AR; Jackson MA; Niehoff E; Barabell C; Nambu CN; Nakajima E; Reinicke T; Bowes C; Berrios-Mairena CJ; Ofoman O; Kirkpatrick GE; Thierauf JC; Reynolds K; Willers H; Beltran WG; Dighe AS; Saff R; Blumenthal K; Sullivan RJ; Chen YB; Kim A; Bardia A; Balazs AB; Iafrate AJ; Gainor JF
J Clin Oncol; 2022 Jan; 40(1):12-23. PubMed ID: 34752147
[TBL] [Abstract][Full Text] [Related]
18. Impacts of the COVID-19 pandemic on early detection of prostate cancer in Australia.
Ip CCK; Kealey J; Davis ID; Sengupta S
BJU Int; 2021 Dec; 128 Suppl 3(Suppl 3):6-8. PubMed ID: 34750958
[No Abstract] [Full Text] [Related]
19. The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J
J Urol; 2020 May; 203(5):910-917. PubMed ID: 31825297
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
